Skip to main content
Premium Trial:

Request an Annual Quote

Two German Research Institutes License Spotfire DecisionSite

NEW YORK, April 6 (GenomeWeb News) - Spotfire said today that Germany's Max Planck Institute of Biochemistry in Martinsried and the German Cancer Research Center in Heidelberg have licensed the company's software.


The research institutes are both using Spotfire's DecisionSite for Functional Genomics, an application for analyzing gene expression patterns and other biological data.


Both institutions will also use DecisionSite Posters to share analysis results across research teams, Spotfire said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.